Metyrapone, an inhibitor of cytochrome oxidases, does not affect viability in a neuroblastoma cell model of bilirubin toxicity

Background: Unconjugated hyperbilirubinemia may cause brain damage in infants, and globally remains a source of neonatal morbidity and mortality. A significant inter-individual variability in vulnerability to bilirubin toxicity remains largely unexplained. An enzyme located in mitochondria oxidizes...

Full description

Bibliographic Details
Main Authors: Maria N. Naguib Leerberg, Tomas N. Alme, Thor W.R. Hansen
Format: Article
Language:English
Published: Elsevier 2014-01-01
Series:Molecular Genetics and Metabolism Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214426914000305
_version_ 1818385334973497344
author Maria N. Naguib Leerberg
Tomas N. Alme
Thor W.R. Hansen
author_facet Maria N. Naguib Leerberg
Tomas N. Alme
Thor W.R. Hansen
author_sort Maria N. Naguib Leerberg
collection DOAJ
description Background: Unconjugated hyperbilirubinemia may cause brain damage in infants, and globally remains a source of neonatal morbidity and mortality. A significant inter-individual variability in vulnerability to bilirubin toxicity remains largely unexplained. An enzyme located in mitochondria oxidizes bilirubin. We hypothesized that inhibiting bilirubin oxidation in human neuronal cell cultures exposed to bilirubin would increase cell death. Methods: The ability of mitochondrial membranes from CHP-212 human neuroblastoma cells to oxidize bilirubin was verified by spectrophotometry. Intact cells in culture were exposed to bilirubin (75 μM) with or without metyrapone (250 μM) for 24 h, stained with Annexin-V and Propidium iodide and analyzed for apoptosis and necrosis by flow cytometry. Results: Bilirubin caused a significant reduction of viability, from 84 ± 2.0% (mean ± SEM) vs 67 ± 2.7% (p < 0.05), but adding metyrapone to the bilirubin-exposed cells did not further impact cell viability. Metyrapone alone did not influence cell viability. Conclusion: Herein we have shown that metyrapone does not increase cell death in neuroblastoma cells in culture exposed to bilirubin. Our results question the relationship between the oxidative mechanism evaluated by spectrophotometry and cell viability. Our findings add to the discussion on whether bilirubin oxidation represents a potentially important protective mechanism in neurons challenged by hyperbilirubinemia.
first_indexed 2024-12-14T03:36:31Z
format Article
id doaj.art-ebc442da1dd84278b8e884c9dc63138e
institution Directory Open Access Journal
issn 2214-4269
language English
last_indexed 2024-12-14T03:36:31Z
publishDate 2014-01-01
publisher Elsevier
record_format Article
series Molecular Genetics and Metabolism Reports
spelling doaj.art-ebc442da1dd84278b8e884c9dc63138e2022-12-21T23:18:36ZengElsevierMolecular Genetics and Metabolism Reports2214-42692014-01-011C19720210.1016/j.ymgmr.2014.04.002Metyrapone, an inhibitor of cytochrome oxidases, does not affect viability in a neuroblastoma cell model of bilirubin toxicityMaria N. Naguib Leerberg0Tomas N. Alme1Thor W.R. Hansen2Department of Pediatric Research, Oslo University Hospital, University of Oslo, NorwayDepartment of Pediatric Research, Oslo University Hospital, University of Oslo, NorwayDepartment of Neonatology, Women & Children's Division, Oslo University Hospital, Rikshospitalet, Oslo, NorwayBackground: Unconjugated hyperbilirubinemia may cause brain damage in infants, and globally remains a source of neonatal morbidity and mortality. A significant inter-individual variability in vulnerability to bilirubin toxicity remains largely unexplained. An enzyme located in mitochondria oxidizes bilirubin. We hypothesized that inhibiting bilirubin oxidation in human neuronal cell cultures exposed to bilirubin would increase cell death. Methods: The ability of mitochondrial membranes from CHP-212 human neuroblastoma cells to oxidize bilirubin was verified by spectrophotometry. Intact cells in culture were exposed to bilirubin (75 μM) with or without metyrapone (250 μM) for 24 h, stained with Annexin-V and Propidium iodide and analyzed for apoptosis and necrosis by flow cytometry. Results: Bilirubin caused a significant reduction of viability, from 84 ± 2.0% (mean ± SEM) vs 67 ± 2.7% (p < 0.05), but adding metyrapone to the bilirubin-exposed cells did not further impact cell viability. Metyrapone alone did not influence cell viability. Conclusion: Herein we have shown that metyrapone does not increase cell death in neuroblastoma cells in culture exposed to bilirubin. Our results question the relationship between the oxidative mechanism evaluated by spectrophotometry and cell viability. Our findings add to the discussion on whether bilirubin oxidation represents a potentially important protective mechanism in neurons challenged by hyperbilirubinemia.http://www.sciencedirect.com/science/article/pii/S2214426914000305BilirubinNeurotoxicityCell cultureKernicterusCytochrome P450 oxidaseMetyrapone
spellingShingle Maria N. Naguib Leerberg
Tomas N. Alme
Thor W.R. Hansen
Metyrapone, an inhibitor of cytochrome oxidases, does not affect viability in a neuroblastoma cell model of bilirubin toxicity
Molecular Genetics and Metabolism Reports
Bilirubin
Neurotoxicity
Cell culture
Kernicterus
Cytochrome P450 oxidase
Metyrapone
title Metyrapone, an inhibitor of cytochrome oxidases, does not affect viability in a neuroblastoma cell model of bilirubin toxicity
title_full Metyrapone, an inhibitor of cytochrome oxidases, does not affect viability in a neuroblastoma cell model of bilirubin toxicity
title_fullStr Metyrapone, an inhibitor of cytochrome oxidases, does not affect viability in a neuroblastoma cell model of bilirubin toxicity
title_full_unstemmed Metyrapone, an inhibitor of cytochrome oxidases, does not affect viability in a neuroblastoma cell model of bilirubin toxicity
title_short Metyrapone, an inhibitor of cytochrome oxidases, does not affect viability in a neuroblastoma cell model of bilirubin toxicity
title_sort metyrapone an inhibitor of cytochrome oxidases does not affect viability in a neuroblastoma cell model of bilirubin toxicity
topic Bilirubin
Neurotoxicity
Cell culture
Kernicterus
Cytochrome P450 oxidase
Metyrapone
url http://www.sciencedirect.com/science/article/pii/S2214426914000305
work_keys_str_mv AT mariannaguibleerberg metyraponeaninhibitorofcytochromeoxidasesdoesnotaffectviabilityinaneuroblastomacellmodelofbilirubintoxicity
AT tomasnalme metyraponeaninhibitorofcytochromeoxidasesdoesnotaffectviabilityinaneuroblastomacellmodelofbilirubintoxicity
AT thorwrhansen metyraponeaninhibitorofcytochromeoxidasesdoesnotaffectviabilityinaneuroblastomacellmodelofbilirubintoxicity